Khalid A. Khabar

P3354, MBC-03, Takhasusi Road
Riyadh, 11211, Saudi Arabia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications

Profound alterations of cancer transcriptomes by the RNase L inhibitor ABCE1 through the modulation of UU/UA-dinucleotide rich transcript abundance.

Profound alterations of cancer transcriptomes by the RNase L inhibitor ABCE1 through the modulation of UU/UA-dinucleotide rich transcript abundance.

Journal: RNA biology
Published: February 09, 2026

All screens lead to polo-like kinase 1: A central node in cancer therapeutics and resistance.

All screens lead to polo-like kinase 1: A central node in cancer therapeutics and resistance.

Journal: Pharmacological research
Published: February 04, 2026

Spaceflight alters molecular networks linked to diverse human diseases in a single cellular model.

Spaceflight alters molecular networks linked to diverse human diseases in a single cellular model.

Journal: Science advances
Published: January 02, 2026

Genome-wide transcriptome analysis and drug target discovery reveal key genes and pathways in thyroid cancer metastasis.

Genome-wide transcriptome analysis and drug target discovery reveal key genes and pathways in thyroid cancer metastasis.

Journal: Frontiers in endocrinology
Published: October 20, 2024

Hydroxychloroquine attenuates double-stranded RNA-stimulated hyper-phosphorylation of tristetraprolin/ZFP36 and AU-rich mRNA stabilization.

Hydroxychloroquine attenuates double-stranded RNA-stimulated hyper-phosphorylation of tristetraprolin/ZFP36 and AU-rich mRNA stabilization.

Journal: Immunology
Published: January 10, 2024

Post-transcriptional regulation of BIRC5/survivin expression and induction of apoptosis in breast cancer cells by tristetraprolin.

Post-transcriptional regulation of BIRC5/survivin expression and induction of apoptosis in breast cancer cells by tristetraprolin.

Journal: RNA biology
Published: December 19, 2023

Global analysis of the abundance of AU-rich mRNAs in response to glucocorticoid treatment.

Global analysis of the abundance of AU-rich mRNAs in response to glucocorticoid treatment.

Journal: Scientific reports
Published: August 24, 2023

Beyond the exome: utility of long-read whole genome sequencing in exome-negative autosomal recessive diseases.

Beyond the exome: utility of long-read whole genome sequencing in exome-negative autosomal recessive diseases.

Journal: Genome medicine
Published: July 27, 2023

β-catenin attenuation leads to up-regulation of activating NKG2D ligands and tumor regression in BrafV600E-driven thyroid cancer cells.

β-catenin attenuation leads to up-regulation of activating NKG2D ligands and tumor regression in BrafV600E-driven thyroid cancer cells.

Journal: Frontiers in immunology
Published: February 22, 2023

Differential upregulation of AU-rich element-containing mRNAs in COVID-19.

Differential upregulation of AU-rich element-containing mRNAs in COVID-19.

Journal: Human genomics
Published: September 05, 2022

Post-transcriptional screen of cancer amplified genes identifies ERBB2/Her2 signaling as AU-rich mRNA stability-promoting pathway.

Post-transcriptional screen of cancer amplified genes identifies ERBB2/Her2 signaling as AU-rich mRNA stability-promoting pathway.

Journal: Oncogenesis
Published: March 17, 2021

β-Catenin Attenuation Inhibits Tumor Growth and Promotes Differentiation in a BRAFV600E-Driven Thyroid Cancer Animal Model.

β-Catenin Attenuation Inhibits Tumor Growth and Promotes Differentiation in a BRAFV600E-Driven Thyroid Cancer Animal Model.

Journal: Molecular cancer therapeutics
Published: January 13, 2021
Showing 1-12 of 43

Last Updated: 09/26/2026